References

Acute kidney injury

10.1016/s0140-6736(24)02385-7 · 2025 · External reference

Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection

10.1038/s41581-021-00394-7 · 2021 · External reference

Global epidemiology and outcomes of acute kidney injury

10.1038/s41581-018-0052-0 · 2018 · External reference

Critical care nephrology: Core curriculum 2020

10.1053/j.ajkd.2019.10.010 · 2020 · External reference

Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis

10.1681/asn.2020101455 · 2021 · External reference

Cisplatin-induced renal injury is independently mediated by OCT2 and p53

10.1158/1078-0432.ccr-14-0319 · 2014 · External reference

Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin

10.1016/j.phrs.2016.05.012 · 2016 · External reference

Cisplatin nephrotoxicity: new insights and therapeutic implications

10.1038/s41581-022-00631-7 · 2023 · External reference

Mitochondrial superoxide dismutase in cisplatin-induced kidney injury

10.3390/antiox10091329 · 2021 · External reference

Regulated cell death in AKI

10.1681/asn.2014030262 · 2014 · External reference

Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases

10.7150/ijbs.85674 · 2023 · External reference

Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism

10.1097/cm9.0000000000002533 · 2023 · External reference

ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury

10.1016/j.redox.2022.102262 · 2022 · External reference

Lipid peroxidation, ferroptosis, and antioxidants

10.1016/j.freeradbiomed.2025.05.393 · 2025 · External reference

NRF2, a superstar of ferroptosis

10.3390/antiox12091739 · 2023 · External reference

NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis

10.1016/j.redox.2019.101107 · 2019 · External reference

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases

10.1038/s41392-023-01720-0 · 2023 · External reference

The structure and functions of PRMT5 in human diseases

10.3390/life11101074 · 2021 · External reference

Protein arginine methyltransferase PRMT5 regulates fatty acid metabolism and lipid droplet biogenesis in white adipose tissues

2020 · External reference

PRMT5 regulates ATF4 transcript splicing and oxidative stress response

10.1016/j.redox.2022.102282 · 2022 · External reference

RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation

10.1016/j.cmet.2025.05.014 · 2025 · External reference

Protein arginine methylation: from enigmatic functions to therapeutic targeting

10.1038/s41573-021-00159-8 · 2021 · External reference

Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

10.1136/gutjnl-2024-332998 · 2024 · External reference

Arginine methylation in cancer: mechanisms and therapeutic implications

10.1186/s40364-025-00860-5 · 2025 · External reference

Prmt5 is essential for intestinal stem cell maintenance and homeostasis

10.1186/s13619-024-00216-8 · 2025 · External reference

Brg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells

10.1152/ajplung.00248.2023 · 2024 · External reference

Kidney disease models: tools to identify mechanisms and potential therapeutic targets

2018 · External reference

PRMT5 inhibition promotes PD-L1 expression and immuno-resistance in lung cancer

10.3389/fimmu.2021.722188 · 2022 · External reference

Identification of METTL3 and PRMT5 as an oncogenic pair for the prognosis and therapeutic targets of colorectal cancer subtype

10.1186/s13148-026-02144-7 · 2026 · External reference

Cloperastine reduces IL-6 expression via Akt/GSK3/Nrf2 signaling in monocytes/macrophages and ameliorates symptoms in a mouse sepsis model induced by lipopolysaccharide

10.1248/bpb.b24-00472 · 2024 · External reference

Cloperastine rescues impairment of passive avoidance response in mice prenatally exposed to diethylstilbestrol

10.1002/tox.21749 · 2012 · External reference

Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury

10.1016/j.celrep.2019.09.050 · 2019 · External reference

Loss of cGAS facilitates angiogenesis in diabetic foot ulcer healing by suppressing the STING/Ferroptosis pathway

10.1016/j.intimp.2026.116684 · 2026 · External reference

Roles of H3K4 methylation in biology and disease

10.1016/j.tcb.2024.06.001 · 2024 · External reference

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

10.1016/j.gendis.2022.04.001 · 2022 · External reference

Renal endothelial injury and microvascular dysfunction in acute kidney injury

10.1016/j.semnephrol.2015.01.010 · 2015 · External reference

Inflammation in AKI: current understanding, key questions, and knowledge gaps

10.1681/asn.2015030261 · 2015 · External reference

Macrophage-driven inflammation in acute kidney injury: therapeutic opportunities and challenges

10.1016/j.trsl.2025.02.003 · 2025 · External reference

Nonapoptotic cell death in acute kidney injury and transplantation

10.1016/j.kint.2015.10.008 · 2016 · External reference

Cell death induced by acute renal injury: a perspective on the contributions of accidental and programmed cell death

10.1152/ajprenal.00275.2023 · 2024 · External reference

Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications

10.1038/s41581-018-0103-6 · 2019 · External reference

Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes

10.1016/j.kint.2024.10.031 · 2024 · External reference

The role and mechanism of lysine methyltransferase and arginine methyltransferase in kidney diseases

2022 · External reference

Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling

10.1152/ajprenal.00487.2019 · 2019 · External reference

Trans-omic analysis identifies the 'PRMT1-STAT3-Integrin αVβ6 Axis' as a novel therapeutic target in tacrolimus-induced chronic nephrotoxicity

10.3390/ijms262110282 · 2025 · External reference

Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy

10.1016/j.cellsig.2014.04.008 · 2014 · External reference

The PRMT6/STAT1/ACSL1 axis promotes ferroptosis in diabetic nephropathy

10.1038/s41418-024-01357-8 · 2024 · External reference

FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways

10.1016/j.molcel.2023.07.004 · 2023 · External reference

The interaction between ferroptosis and necroptosis in acute and chronic kidney diseases

10.2147/jir.s559198 · 2026 · External reference

The cell biology of ferroptosis

10.1038/s41580-024-00703-5 · 2024 · External reference

Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells

10.1042/bsr20212433 · 2022 · External reference

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects

10.1038/s41392-024-01969-z · 2024 · External reference

Antioxidant systems as modulators of ferroptosis: focus on transcription factors

10.3390/antiox13030298 · 2024 · External reference

HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program

10.1002/cac2.12284 · 2022 · External reference

Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice

10.1038/s41467-024-46711-z · 2024 · External reference

Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis

10.1038/s41467-019-11696-7 · 2019 · External reference

Targeting WD repeat-containing protein 5 (WDR5): a medicinal chemistry perspective

10.1021/acs.jmedchem.1c00037 · 2021 · External reference

Lateral thinking: how histone modifications regulate gene expression

10.1016/j.tig.2015.10.007 · 2015 · External reference

Unresolved reference

2025 · External reference

PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer

10.1038/s41556-025-01610-3 · 2025 · External reference

Mechanisms and models of kidney tubular necrosis and Nephron loss

10.1681/asn.2021101293 · 2022 · External reference

The road from AKI to CKD: molecular mechanisms and therapeutic targets of ferroptosis

10.1038/s41419-023-05969-9 · 2023 · External reference

Pharmacological and clinical overview of cloperastine in treatment of cough

2011 · External reference

Pharmacokinetics, bioequivalence and safety of cloperastine in Chinese healthy subjects under fasting and postprandial conditions

10.1007/s40268-022-00406-2 · 2022 · External reference

Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules

10.1002/med.21532 · 2018 · External reference